Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | AdiraMedica Hyoscine Butylbromide 10mg |
| Active Ingredient: | Hyoscine butylbromide 10mg |
| Dosage Form: | Coated tablet |
| New Zealand Sponsor: | AdiraMedica Pty Limited |
| Manufacturer: | Sunglow Lifescience Private Limited, Kattankulam Village, India |
| Product: | AdiraMedica Hyoscine Butylbromide 20mg |
| Active Ingredient: | Hyoscine butylbromide 20mg |
| Dosage Form: | Coated tablet |
| New Zealand Sponsor: | AdiraMedica Pty Limited |
| Manufacturer: | Sunglow Lifescience Private Limited, Kattankulam Village, India |
| Product: | Cequa |
| Active Ingredient: | Ciclosporin 0.9mg/mL |
| Dosage Form: | Eye drops, solution |
| New Zealand Sponsor: | CARSL Consulting |
| Manufacturer: | Laboratoire Unither, Coutances, France |
| Product: | Nurofen Meltlets Berry Burst (General sale) |
| Active Ingredient: | Ibuprofen 200mg |
| Dosage Form: | Orodispersible tablet |
| New Zealand Sponsor: | Reckitt Benckiser (New Zealand) Limited |
| Manufacturer: | Reckitt Benckiser Healthcare International Limited, Nottingham, United Kingdom |
| Product: | Nurofen Meltlets Berry Burst (Pharmacy only) |
| Active Ingredient: | Ibuprofen 200mg |
| Dosage Form: | Orodispersible tablet |
| New Zealand Sponsor: | Reckitt Benckiser (New Zealand) Limited |
| Manufacturer: | Reckitt Benckiser Healthcare International Limited, Nottingham, United Kingdom |
Dated this 8th day of February 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).